Cardiogenesis Inactive 10-K2004 FY Annual report

Filed: 31 Mar 05, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: ablate, abnormal, absent, Academy, accretion, add, advice, aerospace, Allergan, Alliance, analyzing, appointed, ARB, arena, Army, Arthur, attest, Award, bankruptcy, Barbara, Basket, bifurcated, Binomial, biology, biotech, Canada, Captain, cardiology, Carl, case, Cayman, cell, celleratOR, centrifuge, Chapter, Chatsworth, chemist, Chemistry, clause, committed, compatibility, covenant, criterion, de, deem, deemed, delinquency, deposit, deposited, deter, deterrent, detrimental, Devon, devote, discourage, dismissed, distributor, double, earning, EITF, embedded, embraced, encumbrance, enterprise, excelled, excessive, feature, feel, finite, firm, foreclose, formally, freight, fulfill, Gerard, growing, hand, heard, holder, idle, Imaging, Infantry, inside, insolvency, Intelligent, investor, Ireland, Janet, Jolla, Journal, judgment, La, laboratory, Langford, Langfordjoined, Lbs, Lee, lieu, Limerick, literally, lived, Marine, Master, MCAC, ment, met, Military, Mississippi, mitigated, mix, mm, monetary, monthly, oncology, Oversight, Pacific, partner, Pearl, Pharmaceutical, physiologic, plasma, platelet, platform, PMC, possession, preceding, precise, premature, prescribed, probablility, promptly, protocol, PRP, quantity, Radar, Radio, Ranger, rank, rare, reach, recovered, redemption, refusal, rehandling, released, rename, repay, repayment, retroactive, retroactively, retrospectively, revised, rich, robotic, robotically, rulemaking, Santa, School, shown, situation, SolarGen, speculative, spending, spoilage, stage, stop, Street, surviving, suspended, tender, testimony, thoracoscopic, threshold, tied, today, trustee, twenty, type, unamortized, uncollectible, underperformance, understood, unresolved, unrestricted, unspecified, unvested, usage, valuable, veteran, Villanova, voluntary, wasted, west, yield

Removed: Agent, apply, attributable, auditing, book, borrowing, commodity, confirming, conventional, dated, Dr, East, EquiServe, existed, exploring, half, Indemnification, jointly, Middle, negotiated, original, page, prioritized, ratifying, recoverability, relocation, signature, strategy, streamlining, substitute, substitution, Suite, Sunnyvale, termination, Towne, Trust, virtue

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Cardiogenesis similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 10.11

Amendment No. 2 to Employment Agreement
Dated September 27, 2001
Between Cardiogenesis Corporation as Company and
Michael J. Quinn as Executive

The terms and conditions of the Employment Agreement are hereby modified and amended as follows. Unless specifically defined in this Agreement, capitalized terms used herein shall have the meanings ascribed to them in the Employment Agreement.

Section 3.1, line 2, after “Three Hundred Thirty Thousand Dollars ($330,000) per annum” insert “and effective January 1, 2003, such salary shall be increased to an amount equal to Three Hundred Eighty Eight Dollars Four Hundred Twenty Seven ($388,427) per annum”.

All other terms and conditions of the Employment Agreement shall remain the same.

IN WITNESS THEREOF, the parties hereto have executed this Amendment of the latest date set forth below.


COMPANY:		EXECUTIVE:
CARDIOGENESIS CORPORATION		MICHAEL J. QUINN

BY:	Darrell Eckstein	BY:	Michael Quinn


NAME:	Darrell Eckstein	NAME:	Michael Quinn


TITLE:	President, CFO	TITLE:	CEO & Chairman


DATE:	5/19/03	DATE:	5/19/03

Amendment No. 3 to Employment Agreement
Dated September 27, 2001
Between Cardiogenesis Corporation as Company and
Michael J. Quinn as Executive

Section 3.1, line 2, after “Three Hundred Thirty Thousand Dollars ($330,000) per annum” insert “and effective January 1, 2005, such salary shall be increased to an amount equal to Four Hundred Thirty-Six Thousand Six Hundred Fifty Dollars ($436,650) per annum”.

All other terms and conditions of the Employment Agreement shall remain the same.

IN WITNESS THEREOF, the parties hereto have executed this Amendment of the latest date set forth below.


COMPANY:		EXECUTIVE:
CARDIOGENESIS CORPORATION		MICHAEL J. QUINN

BY:	Christine Ocampo	BY:	Michael J. Quinn


NAME:	Christine Ocampo	NAME:	Michael J. Quinn


TITLE:	VP, Chief Financial Officer	TITLE:	President and CEO


DATE:	3/16/05	DATE:	3/16/05

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.